US/UK/Canada

Share

Quotes

In spearheading our adoption of Medidata Detect, we're not only reinforcing our commitment to data quality and patient safety, but we're also embracing a pivotal enhancement to our existing technology stack. Our partnership with Medidata now extends beyond the realms of Rave® EDC, CTMS, and eTMF, illustrating a significant step in our long-term strategy to advance clinical trial efficiency through innovation.
Michael Mendoza, Executive Director of eClinical Technology and Biometrics, TFS HealthScience
We are thrilled to be the first CRO implementing Medidata’s Detect platform, which addresses many data inefficiencies the industry experiences today. Using a centralized data management system will enhance data quality, risk management, and decision-making, fast-tracking clinical trials for clients and the availability of drugs for patients.
Dr. Bassem Saleh, Chief Executive Officer, TFS HealthScience
At Medidata, we’re collaborating with our 2,300+ global customers to accelerate clinical trials by developing new, scalable data experiences that improve quality, maximize efficiency, and better support patients. Medidata Detect will give TFS HealthScience a competitive advantage with AI-driven insights and task automation that reduce the time to high-quality data and bring operational teams closer, eliminating redundancies and aligning processes across the organization.
Tom Doyle, Chief Technology Officer, Medidata
Pick a time period -
Tags ( Active)

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

New messaging reflects TFS's commitment to patient-centered clinical research and global partnershipsLUND, S.E., September 19, 2024 - TFS HealthScience (TFS) , a leading global Contract Research Organization (CRO), proudly announces the launch of its new mission statement and tagline: Empowering Partners. Enriching Lives. This strategic shift underscores TFS’s commitment to advancing clinical research, improving patient outcomes, and fostering sustainable partnerships. The refreshed mission—to empower partners to advance treatments that promote global health and well-

TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation

LUND, S.E., March 11, 2024 – TFS HealthScience (TFS) , a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia. This strategic move marks a significant milestone in TFS's commitment to providing comprehensive clinical research services and supporting partners with a broader reach to patients, fostering innovative solutions and global collaboration.The APAC region presents a promising

TFS HealthScience Becomes First CRO to Adopt Medidata Detect, Improving Data Sharing Efficiency and Product Development

LUND, Sweden (Nov. 6, 2023) - TFS HealthScience, a global contract research organization (CRO), announces its strategic investment in Medidata Detect , a comprehensive data surveillance and risk monitoring solution that improves data quality and promotes patient safety in clinical trials. TFS stands as the first CRO to adopt Medidata Detect technology for its clients.Medidata Detect will help data managers and clinical operations teams to improve patient safety, data quality

TFS HealthScience appoints Chief People Officer

TFS HealthScience, a global mid-size CRO, announced that Eva Brike has joined the company as Chief People Officer. Eva will lead all areas of human resources, and talent strategy, including employee experience, as well as communications for the growing team of over 700 professionals at TFS. The CPO is a new role at TFS and it recognizes the need to further develop the company’s culture. Commenting on this appointment, Bassem Saleh, CEO said: “We believe that scaling our culture requires a holistic and systematic approach. Eva’s reputation for creating trusted partnerships, her commitment

TFS HealthScience appoints new CFO

LUND, Sweden January, 2022:TFS HealthScience has announced the appointment of Jesper Hjort as Chief Financial Officer. Joining from FLSmidth, a listed engineering company, Jesper brings over 14 years of finance experience across financial reporting, governance, risk management and forecasting as well as accounting and auditing. He has spent several years working in companies operating globally. Bassem Saleh, TFS Chief Executive Office commented: “Jesper is a financial executive with a strong background and significant international experience. I am confident that this appointment will

TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development

Veeva Vault unifies clinical documents and processes to improve collaboration and speed execution Veeva Systems  (NYSE: VEEV) today announced that TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations Suite  for end-to-end study management on a single cloud platform. The European-headquartered global CRO is taking action to further modernize the study operations, adopting the entire suite to drive greater efficiency and speed in trials. TFS HealthScience will now be

TFS Awarded EcoVadis Silver

[Sweden, Lund: February 2,2021] TFS, a global CRO partnering with pharma and biotech companies, achieves EcoVadis Silver rating for sustainability. EcoVadis is the world's largest and most trusted independent provider of business sustainability evaluating the performance of over 75,000 companies and their supply chains. The assessment covered compliance in environmental, social and, ethical factors placing TFS in the 4% of companies rated by EcoVadis in the Scientific research and development industry.TFS operates in an industry focused on improving and refining the delivery of better

TFS International Appoints New CFO

LUND, Sweden December 15, 2020 – TFS International is pleased to announce the appointment of René Holmen Pedersen as Chief Financial Officer. He will begin his employment on March 1, 2021 and will be based out of TFS global headquarters in Lund."We are excited to have Rene join TFS. He complements our strong performance-oriented culture and his impressive reputation for strategy, execution and achieving results makes him the right choice to lead our finance operations," commented Bassem Saleh, CEO of TFS. “His skillset fits well with the existing finance organization and will complement our

TFS Announces Partnership with the Duke Clinical Research Institute

Lund, Sweden, September 8: TFS has entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization’s study portfolio. The partnership supports TFS’s growth strategy and aligns its clinical development services with an organization renowned for bringing innovation to clinical trial design and execution. This is a unique collaboration that expands TFS’s capability to execute clinical trials for sponsors in the U.S.  “The DCRI is known for ushering in new and innovative approaches to

Demonstrating strong customer focus and therapeutic expertise, TFS CRO has been awarded new Covid-19 studies.

TFS is working in collaboration with sponsors, at an unprecedented pace. Our operational teams are participating in various studies, targeting coronavirus disease patients or analyzing the real world evidence to bring treatments to COVID-19 patients faster. TFS is continuously recognized for agility as well as the knowledge and experience of our teams. In-depth expertise in the field of internal medicine as well as strong presence in Spain allow TFS to partner with customers on four more trials on Covid-19. The studies total up to more than 3300 patients in 17 sites covering full a

TFS partners with Veeva to offer new, innovative safety database solution for its trials.

Technology continues to advance at an ever-increasing pace. As pressures rise to simultaneously reduce cost whilst increasing regulatory compliance, it is critical now more than ever, that such technologies are widely leveraged to support this objective. Yet for many years, despite their existence, tools to support automation and improve visibility of safety data to aid identification and characterization of risk have not been widely implemented. TFS address this issue through their recent Veeva Vault Safety implementation, which is now available to TFS customers.   Ian Kovacs, Global

TFS forms partnership to conduct a global RWE study on Covid-19 pandemic.

TFS joins Observational Health Data Sciences and Informatics (OHDSI) community in a COVID-19 virtualstudy-a-thon (March 26-29) to inform healthcare decision-making in response to the current globalpandemic. With the increasing availability of real-world COVID-19 data worldwide the main purpose ofthe event is to generate immediate real-world evidence on prioritized questions shared by nationalgovernments, public health agencies, health-related institutions, and community members; and todesign COVID-19-specific studies that can be validated and available to run when such data is

TFS presents TrialOnline - digital solution for patient retention and data collection as an example of a successful industry partnership.

TFS attends ADCM Conference to present a TrialOnline ePRO – a custom patient retention tool developed in successful partnership between a CRO, EDC vendor and pharma. Patient retention represents an important challenge in some therapeutic areas. Many clinical trials are at risk a risk of low patient retention putting study at jeopardy, may be destined to fail due to a low patient retention. In example, the prevalence of chronic psoriasis in Western industrialized countries is around 2% (>30M people). Most treatments have side effects that may lead patients to withdrawn the treatment,

Secrets to Biotech Success, a TFS seminar series, goes to Germany

TFS continues to recognize the importance of partnerships in the clinical development and brings together biotech industry expert, investors and clinical research professionals to discuss the changing landscape of biopharma.The journey from molecule to clinic, through the entire clinical development including securing funds and the selection of a CRO partner were the focus areas of the seminar, which took place at the Bio[M] Munich biotech cluster. This well-recognized science park connects partners from science, industry, medicine and finance. "This series of event reflects TFS’

TFS joins Medidata Partner Program with Rave EDC accreditation.

TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, joins Medidata Partner Program and combines its therapeutic expertise with leading-edge technologies. TFS has been accredited to the Medidata Rave system for electronic data capture and clinical trial management (Rave EDC). The achievement certifies the company to build databases using Medidata Rave and include this widely adopted electronic data capture and clinical data management system in its offerings. Combined with TFS long commitment to operational excellence, this innovative

Dr. Bassem Saleh new Chief Executive Officer of TFS

The Board of Directors of TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, appointed Dr. Bassem Saleh as Chief Executive Officer, effective 17 December 2019. He will succeed Dr. János Filakovský who has led TFS for the last two years positioning the company for a long term growth. Dr. Bassem Saleh has been with TFS since 2017, as the Chief Medical Officer and EVP of Clinical Development Services. Before joining TFS, Dr. Saleh held senior leadership positions and played an integral part in the growth and success of large and mid-size

TFS seminar Secrets to Biotech Success brings together industry stakeholders recognizing a strategic partnership as the foundation of the biotech success.

On September 19th, TFS hosted a seminar in Medicon Village starting a much needed discussion about the changes impacting the biopharmaceutical industry. Representatives from the biotech, academic and investor community came together to share their unique business perspective.A significant and increasing portion of biopharmaceutical R&D worldwide is currently created by small and midsize biotechnology, medical device and medical technology companies. On the other hand, the biotechnology industry is also facing challenges. It’s no longer enough to create products that are innovative, safe and

There are no items matching the current filter
There are no more items matching the current filter
Back to top